In the last years, an increasing number of studies have examined the oncogenic properties of Nrf2 (reviewed in [188]) as shown in lung cancer [189], squamous cell carcinomas of esophagus and skin [190] or hereditary leiomyomatosis and renal cell cancer (HLRCC) [191]. This evidence concerns the gene GABPA and lung carcinoma.